Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.0B | 18.2B | 31.5B | 19.2B |
Cost of revenue | 8.0B | 8.8B | 9.2B | 8.5B |
Gross profit | 9.0B | 9.4B | 22.4B | 10.7B |
Operating expense | ||||
Research & development | 96.3M | 541.4M | 122.9M | 123.1M |
Selling general and admin | 354.9M | -459.7M | 795.4M | -109.4M |
Other operating expenses | 618.1M | 515.6M | 709.2M | 466.8M |
Operating income | 8.0B | 7.6B | 21.2B | 9.8B |
Non operating interest income | ||||
Income | 47.0M | 49.3M | 50.8M | 52.5M |
Expense | 2.5B | 2.7B | 2.9B | 2.8B |
Other income expense | — | — | — | — |
Pretax income | 6.2B | 5.7B | 19.6B | 8.8B |
Tax provision | 913.1M | 1.2B | 2.8B | 1.3B |
Net income | 5.3B | 4.6B | 16.8B | 7.5B |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 24.5B | — | — | — |
Diluted average shares | 24.5B | — | — | — |
EBITDA | 8.8B | 8.5B | 22.4B | 11.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -109.7M | -81.4M | -131.5M | -111.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |